ovarian-cancer

Documents about ovarian-cancer

• Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning#187364arXiv CS
• Clinical outcomes and prognostic factors of low-grade serous ovarian cancer: A single-centre observational retrospective study#200189bioRxiv / medRxiv
• Decoding adaptive cellular mechanisms of cisplatin chemoresistance in ovarian cancer cells#203371Repositorio USS
• Diagnostic accuracy of ovarian cancer using convolutional neural network: a systematic review and meta-analysis.#239731NCBI PubMed Central
• Spatial habitats radiomics from multiparametric magnetic resonance imaging predict platinum resistance in epithelial ovarian cancer.#263093NCBI PubMed Central
• Multimodal Prehabilitation in Indian Women with Advanced Ovarian Cancer: Enhancing Nutritional, Psychological, and Surgical Recovery.#275340NCBI PubMed Central
• A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection.#297268NCBI PubMed Central
• Immunotherapy does not impair ovarian function in a mouse model of breast cancer.#378512NCBI PubMed Central
• Identification of implications of m6A regulators and autophagy-associated genes for prognosis in ovarian cancer#405071bioRxiv / medRxiv
• Single-Cell-Derived Malignant Epithelial Programs Define Prognostic Risk and Therapeutic Vulnerability in Ovarian Cancer.#412198NCBI PubMed Central
• Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making.#457419NCBI PubMed Central
• The future of early cancer detection: emerging diagnostic technologies for liver and ovarian cancers#475686Europe PMC
• Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: The CHIPOR randomized phase III trial.#476019HAL (France)
• T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors#481761ClinicalTrials.gov
• SpiderMass ambient mass spectrometry and multimodal machine learning enable ex vivo ovarian cancer typing and exploratory immunoscoring#676943HAL (France)
• Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study.#823642NCBI PubMed Central
• The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women#877378ClinicalTrials.gov
• Enhance the Use of Genetic Counseling and Testing in Latinas#918778ClinicalTrials.gov
• Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies#885479ClinicalTrials.gov
• Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors#812228ClinicalTrials.gov
• Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors#827956ClinicalTrials.gov
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors#824951ClinicalTrials.gov
• A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors#966510ClinicalTrials.gov
• Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.#454695Lund University Publications
• Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer#843120ClinicalTrials.gov
• TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas#907031ClinicalTrials.gov
• Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer#121848HAL (France)
• A Multiomics and Bioinformatics Analysis of the Role and Mechanism of CNKSR1 in Ovarian Cancer Progression.#4397NCBI PubMed Central
• Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer.#170586NCBI PubMed Central
• Data Management and Sharing Plan for: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy#207837UNC Dataverse Dataverse OAI Archive
• The Role of YouTube as an Information Platform for Ovarian Cancer: the Educational Quality and Reliability.#247821NCBI PubMed Central
• Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)#257499HAL (France)
• Applications of artificial intelligence and machine learning models in the prognosis and diagnosis of ovarian cancer.#269583NCBI PubMed Central
• Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention.#334726NCBI PubMed Central
• Multi-omics-driven kinetic modeling reveals metabolic vulnerabilities and differential drug-response dynamics in ovarian cancer#354228Infoscience
• Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study.#368183NCBI PubMed Central
• Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer#374393HAL (France)
• Configurational Paths of Depression and Anxiety Symptoms in Ovarian Cancer Patients: A Fuzzy-Set Qualitative Comparative Analysis.#382330NCBI PubMed Central
• Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology#849293ClinicalTrials.gov
• Early Detection of Cancers in Low Resource Countries#860095ClinicalTrials.gov
• Phase 1 Dose Escalation of ArtemiCoffee#864921ClinicalTrials.gov
• Genetic Testing Decision Aid#868004ClinicalTrials.gov
• Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors#850140ClinicalTrials.gov
• A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors#467592ClinicalTrials.gov
• [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications#826631ClinicalTrials.gov
• A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors#905857ClinicalTrials.gov
• Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations#907095ClinicalTrials.gov
• A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors#880988ClinicalTrials.gov
• A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers#853211ClinicalTrials.gov
• Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.#208451ClinicalTrials.gov